Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
VM.V
Strong SellHot AirVoyageur Pharmaceuticals Ltd. · Healthcare · Canada · $28M · Avg Vol: $19K/d
19
StockRankGet insider-trade alerts
Q
19
V
19
M
64
P/E (TTM)
—
ROE
-574.2%
D/E
0.1x
Dividend %
—
COMPANY DESCRIPTION
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs.
FINANCIAL SUMMARY (CAD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 11.7K | — | 47.0K |
| EPS (CAD) | -0.02 | -0.01 | -0.01 | -0.02 | — | -0.02 |
| Shares | 115.4M | 132.7M | 139.5M | 178.6M | +54.7% | 226.3M |
| Debt | 25.5K | 40.0K | 40.0K | 40.0K | 16.2% | 39.8K |
| Equity | 1.5M | 1.4M | 0.4M | 1.3M | -5.1% | — |
| Op CF | -1.7M | -1.0M | -0.3M | -2.9M | — | -1.3M |
| Inv CF | -0.3M | -0.2M | -0.2M | -0.3M | — | — |
| Fin CF | 1.2M | 1.1M | 0.6M | 3.3M | — | — |
Loading 1Y...
PRICE (1Y)+17.9%
SMA 50SMA 200
Close
$0.1192
RSI (14)
54.5
52W High
$0.1409
From 52W High
0.8%
SCORE BREAKDOWN
Quality
19
ROIC
-273.3%1.9
ROE
-574.2%1.7
GP/Assets
0.0%10.4
Op. Margin
-5312.7%3.7
FCF/Assets
-12.3%28.9
Piotroski
440.5
Int. Cover
—N/A
D/E Ratio
0.10x62.5
Current Ratio
0.23x1.1
Value
19
P/E (TTM)
—N/A
EV/EBITDA
-11.5x25.0
P/FCF
—N/A
P/B
42.5x2.4
P/S
814.5x2.8
Div Yield
—N/A
Momentum
64
52W High %
85%75.6
RS 6M
5%69.3
SMA 50/200
1.07x72.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$28M
P/E (Forward)
—
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of VM.V are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| VM.V | Voyageur Pharmaceuticals Ltd.(you) | $28M | 19 | Strong Sell |
| MLCO.CN | The More Life Company Corp. | $26M | 23 | Sell |
| LSL.V | LSL Pharma Group Inc. | $30M | 15 | Strong Sell |
| OPTI.CN | Optimi Health Corp. | $27M | 12 | Strong Sell |
| NVRS.CN | Noveris Health Sciences Inc. | $55M | 3 | Strong Sell |
| ROMJ.V | Rubicon Organics Inc. | $29M | 53 | Hold |
| LEEF.CN | Leef Brands Inc. | $58M | 42 | Hold |
| CRDL | Cardiol Therapeutics Inc. | $227M | 23 | Sell |
| CGC | Canopy Growth Corporation | $475M | 19 | Strong Sell |
| DB.V | Decibel Cannabis Company Inc. | $51M | 67 | Buy |
Peer medians: ROE -34.8% · P/E 17.3x · Gross margin 44.6%